Imiquimod 5% tópico como terapia alternativa en carcinoma basocelular periocular en 2 pacientes con contraindicación quirúrgica / Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication
Arch. Soc. Esp. Oftalmol
; 92(2): 93-96, feb. 2017. ilus
Article
in Spanish
| IBECS
| ID: ibc-160379
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
CASO CLÍNICOS Presentamos los casos de dos pacientes con carcinoma basocelular periocular palpebral, que recibieron imiquimod tópico al 5%, con buena respuesta. Ambos presentaban un estado funcional que desaconsejaba el tratamiento quirúrgico. CONCLUSIÓN:
La crema de imiquimod al 5% ha demostrado ser una alternativa eficaz al tratamiento quirúrgico de tumores basocelulares perioculares, especialmente en aquellos casos en los que la cirugía no es posibleABSTRACT
CLINICAL CASE The cases are presented of two patients with periocular basal cell carcinoma of the eyelid who received topical imiquimod 5%, with a good response. Both had a functional state that contraindicated surgical treatment. CONCLUSION:
Imiquimod cream 5% was shown to be an effective alternative to surgical treatment of periocular basal cell carcinoma, especially in those cases where surgery is not possible
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Carcinoma, Basal Cell
/
Eyelid Neoplasms
/
Immunologic Factors
Type of study:
Diagnostic study
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Arch. Soc. Esp. Oftalmol
Year:
2017
Document type:
Article
Institution/Affiliation country:
Hospital Universitario Central de Asturias/España